Seed Oils: The Raging Health Debate you’ve Never Heard

Physionic

Jun 20, 2025

Episode description

*JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]*
Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2

*HEALTH AUTONOMY [COURSE]*
Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy

*JOIN THE COMMUNITY*
Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2

*EMAIL LIST*
1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6

*HIRE ME FOR CONSULTING:*
Consulting: https://bit.ly/3dmUl2H

Created with Biorender

0:00 - Introduction
1:40 - The Anti-Seed Oil Research
5:24 - The Debate Intensifies
8:59 - What does more recent Research say?
14:33 - Omega-6/Omega-3 Ratio
17:55 - Some Critical Information
23:15 - Main Points

References
[Study 467] Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010;104(11):1586-1600. doi:10.1017/S0007114510004010
Funding/Conflicts: Public Funding [NIAAA and NIH] / No direct Conflicts of Interest

[Study 468] Harris WS, Brouwer IA, Mozaffarian D. n-6 Fatty acids and risk for CHD: consider all the evidence. ​ Br J Nutr. ​ 2011;106(6):951-952. doi:10.1017/S000711451100105X.

Funding/Conflicts: No Funding / Potential direct Conflicts of Interest [Dr. William S. Harris has served as a speaker for GlaxoSmithKline and a consultant for several companies involved in omega-3 fatty acid research and products - truncated]

[Study 469] Ramsden CE, Hibbeln JR, Majchrzak-Hong SF, Davis JM. Don’t disregard the essential distinction between PUFA species. Br J Nutr. 2011;106(7):953-957. doi:10.1017/S0007114511001061

Funding/Conflicts: Public Funding [NIAAA and NIH] / No direct Conflicts of Interest

[Study 470] Hamley S. The effect of replacing saturated fat with mostly n–6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials. Nutr J. 2017;16(1):30. doi:10.1186/s12937-017-0254-5

Funding/Conflicts: None

[Study 471] Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2015;(6):CD011737. doi:10.1002/14651858.CD011737.pub2

Funding/Conflicts: Public Funding [NIH and CLAHRC] / No direct Conflicts of Interest

[Study 472] Wu JHY, Lemaitre RN, Imamura F, et al. Omega-6 fatty acid biomarkers and incident cardiovascular disease and death: an individual-level pooled analysis of 30 prospective cohort studies. Lancet Diabetes Endocrinol. 2014;2(10):856-865. doi:10.1016/S2213-8587(14)70126-2

Funding/Conflicts: Mixed Funding [Non-Profit: Bill & Melinda Gates Foundation; Public: NIH] / No direct Conflicts of Interest

[Study 473] Zhou H, Urpi-Sarda M, Tuladhar AM, et al. Plasma omega-6/omega-3 ratio and mortality: insights from 117,546 UK Biobank participants. eLife. 2022;11:e81751. doi:10.7554/eLife.81751

Funding/Conflicts: Public [National Natural Science Foundation of China] / No direct Conflicts of Interest

[Study 474] Yang WS, Chen YY, Chen PC, et al. Association between Plasma N-6 Polyunsaturated Fatty Acids Levels and the Risk of Cardiovascular Disease in a Community-based Cohort Study. Sci Rep. 2019;9:19298. doi:10.1038/s41598-019-55686-7

Funding/Conflicts: Internal Funding [Department of Internal Medicine at National Taiwan University Hospital] / No direct Conflicts of Interest

[Study 475] Woodhill JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. In: Kritchevsky D, ed. Drugs, Lipid Metabolism, and Atherosclerosis. New York, NY: Plenum Press; 1978:317-330.

Funding/Conflicts: Internal Funding [Department of Medicine, University of New South Wales, at Prince Henry Hospital, Little Bay, Australia] // No direct Conflicts of Interest

[Study 476] Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707. doi:10.1136/bmj.e8707.

Funding/Conflicts: Public Funding [Intramural Research Program of the National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Aging (NIA)] / No direct Conflicts of Interest

[Study 477] Burr ML, Fehily AM, Rogers S, Welsby E, King S, Sandham S. Diet and reinfarction trial (DART): design, recruitment, and compliance. Eur Heart J. 1989;10(6):558-567.

Funding/Conflicts: Mixed Funding [Welsh Scheme for the Development of Health and Social Research, the Welsh Heart Foundation, and the Health Promotion Research Trust] // No direct Conflicts of Interest

Episode description

*JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]*
Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2

*HEALTH AUTONOMY [COURSE]*
Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy

*JOIN THE COMMUNITY*
Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2

*EMAIL LIST*
1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6

*HIRE ME FOR CONSULTING:*
Consulting: https://bit.ly/3dmUl2H

Created with Biorender

0:00 - Introduction
1:40 - The Anti-Seed Oil Research
5:24 - The Debate Intensifies
8:59 - What does more recent Research say?
14:33 - Omega-6/Omega-3 Ratio
17:55 - Some Critical Information
23:15 - Main Points

References
[Study 467] Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010;104(11):1586-1600. doi:10.1017/S0007114510004010
Funding/Conflicts: Public Funding [NIAAA and NIH] / No direct Conflicts of Interest

[Study 468] Harris WS, Brouwer IA, Mozaffarian D. n-6 Fatty acids and risk for CHD: consider all the evidence. ​ Br J Nutr. ​ 2011;106(6):951-952. doi:10.1017/S000711451100105X.

Funding/Conflicts: No Funding / Potential direct Conflicts of Interest [Dr. William S. Harris has served as a speaker for GlaxoSmithKline and a consultant for several companies involved in omega-3 fatty acid research and products - truncated]

[Study 469] Ramsden CE, Hibbeln JR, Majchrzak-Hong SF, Davis JM. Don’t disregard the essential distinction between PUFA species. Br J Nutr. 2011;106(7):953-957. doi:10.1017/S0007114511001061

Funding/Conflicts: Public Funding [NIAAA and NIH] / No direct Conflicts of Interest

[Study 470] Hamley S. The effect of replacing saturated fat with mostly n–6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials. Nutr J. 2017;16(1):30. doi:10.1186/s12937-017-0254-5

Funding/Conflicts: None

[Study 471] Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2015;(6):CD011737. doi:10.1002/14651858.CD011737.pub2

Funding/Conflicts: Public Funding [NIH and CLAHRC] / No direct Conflicts of Interest

[Study 472] Wu JHY, Lemaitre RN, Imamura F, et al. Omega-6 fatty acid biomarkers and incident cardiovascular disease and death: an individual-level pooled analysis of 30 prospective cohort studies. Lancet Diabetes Endocrinol. 2014;2(10):856-865. doi:10.1016/S2213-8587(14)70126-2

Funding/Conflicts: Mixed Funding [Non-Profit: Bill & Melinda Gates Foundation; Public: NIH] / No direct Conflicts of Interest

[Study 473] Zhou H, Urpi-Sarda M, Tuladhar AM, et al. Plasma omega-6/omega-3 ratio and mortality: insights from 117,546 UK Biobank participants. eLife. 2022;11:e81751. doi:10.7554/eLife.81751

Funding/Conflicts: Public [National Natural Science Foundation of China] / No direct Conflicts of Interest

[Study 474] Yang WS, Chen YY, Chen PC, et al. Association between Plasma N-6 Polyunsaturated Fatty Acids Levels and the Risk of Cardiovascular Disease in a Community-based Cohort Study. Sci Rep. 2019;9:19298. doi:10.1038/s41598-019-55686-7

Funding/Conflicts: Internal Funding [Department of Internal Medicine at National Taiwan University Hospital] / No direct Conflicts of Interest

[Study 475] Woodhill JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. In: Kritchevsky D, ed. Drugs, Lipid Metabolism, and Atherosclerosis. New York, NY: Plenum Press; 1978:317-330.

Funding/Conflicts: Internal Funding [Department of Medicine, University of New South Wales, at Prince Henry Hospital, Little Bay, Australia] // No direct Conflicts of Interest

[Study 476] Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707. doi:10.1136/bmj.e8707.

Funding/Conflicts: Public Funding [Intramural Research Program of the National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Aging (NIA)] / No direct Conflicts of Interest

[Study 477] Burr ML, Fehily AM, Rogers S, Welsby E, King S, Sandham S. Diet and reinfarction trial (DART): design, recruitment, and compliance. Eur Heart J. 1989;10(6):558-567.

Funding/Conflicts: Mixed Funding [Welsh Scheme for the Development of Health and Social Research, the Welsh Heart Foundation, and the Health Promotion Research Trust] // No direct Conflicts of Interest

Mindsip insights from this episode:

Understand omega-6 to omega-3 ratio for health risks

Health risks from the omega-6 to omega-3 ratio may only appear at levels of 14:1 or higher, while the average person's blood level is around 9:1, a range associated with no increased risk.

Measure blood omega-6 levels for accurate health risk assessment

Measuring circulating omega-6 levels in your blood is a more accurate biomarker of long-term exposure and health risk than simply tracking dietary consumption.

Prioritize omega-3 intake over omega-6 excess for better health

Researchers suggest that insufficient omega-3 intake is a greater health concern for the average person than an excess of omega-6.

Reevaluate seed oil studies due to trans fat contamination

A key historical study used against seed oils is unreliable because the margarine given to the omega-6 group likely contained trans fats, a now-banned and extremely harmful substance.

Consider calorie intake alongside seed oil consumption

In the Rose Corn Oil trial, a study used to argue against seed oils, the group consuming corn oil also consumed 700 more calories per day, making it impossible to blame the oil alone.

Challenge flawed science against seed oils

The scientific case against seed oils is built on inconsistent analyses of old, deeply flawed studies, including one where over 70% of participants dropped out.

Choose healthy alternatives to replace seed oils

When you avoid seed oils, what you replace them with matters, as some alternatives like certain saturated fats could be more harmful to your health.

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius